AIM ImmunoTech Inc (AIM)
0.2117
+0.01
(+5.85%)
USD |
NYAM |
Nov 21, 16:00
0.2121
0.00 (0.00%)
After-Hours: 05:42
AIM ImmunoTech Enterprise Value: 9.017M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 9.017M |
| November 20, 2024 | 8.271M |
| November 19, 2024 | 7.188M |
| November 18, 2024 | 10.21M |
| November 15, 2024 | 9.736M |
| November 14, 2024 | 11.63M |
| November 13, 2024 | 10.95M |
| November 12, 2024 | 10.82M |
| November 11, 2024 | 10.25M |
| November 08, 2024 | 11.07M |
| November 07, 2024 | 11.11M |
| November 06, 2024 | 11.44M |
| November 05, 2024 | 11.46M |
| November 04, 2024 | 11.90M |
| November 01, 2024 | 12.16M |
| October 31, 2024 | 12.09M |
| October 30, 2024 | 11.65M |
| October 29, 2024 | 12.73M |
| October 28, 2024 | 12.73M |
| October 25, 2024 | 12.44M |
| October 24, 2024 | 12.03M |
| October 23, 2024 | 11.99M |
| October 22, 2024 | 12.56M |
| October 21, 2024 | 12.30M |
| October 18, 2024 | 11.39M |
| Date | Value |
|---|---|
| October 17, 2024 | 11.93M |
| October 16, 2024 | 11.99M |
| October 15, 2024 | 11.80M |
| October 14, 2024 | 11.93M |
| October 11, 2024 | 12.37M |
| October 10, 2024 | 12.18M |
| October 09, 2024 | 11.87M |
| October 08, 2024 | 12.12M |
| October 07, 2024 | 12.56M |
| October 04, 2024 | 12.22M |
| October 03, 2024 | 10.85M |
| October 02, 2024 | 11.04M |
| October 01, 2024 | 11.68M |
| September 30, 2024 | 11.37M |
| September 27, 2024 | 8.574M |
| September 26, 2024 | 8.003M |
| September 25, 2024 | 6.460M |
| September 24, 2024 | 7.666M |
| September 23, 2024 | 7.014M |
| September 20, 2024 | 7.843M |
| September 19, 2024 | 9.203M |
| September 18, 2024 | 9.620M |
| September 17, 2024 | 10.35M |
| September 16, 2024 | 9.546M |
| September 13, 2024 | 9.540M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-21.35M
Minimum
Dec 29 2022
152.07M
Maximum
Mar 09 2020
19.17M
Average
9.224M
Median
Jan 05 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -63.40M |
| Protalix BioTherapeutics Inc | 94.82M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
| Armata Pharmaceuticals Inc | 166.25M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.70M |
| Revenue (Quarterly) | 0.035M |
| Total Expenses (Quarterly) | 4.524M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 77.14% |
| Profit Margin (Quarterly) | -10.57K% |
| Earnings Yield | -222.0% |
| Normalized Earnings Yield | -222.41 |